FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies

News   Jun 23, 2017 | Original story from Thermo Fisher Scientific

 
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for  Multiple Non-Small Cell Lung Cancer Therapies
 
 
 

RELATED ARTICLES

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

Genetic Code of Neuronal Communication Determines Cell Type

News

The findings should help scientists sort out the bewildering array of neurons that are intertwined in the brain.

READ MORE

Human Microbiome Project: Millions of New Genes Identified

News

A new study of the human microbiome, the trillions of microbial organisms that live on and within our bodies, has uncovered millions of previously unknown genes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE